Search

Search Results

• 

  Prolonged and biphasic acute hepatitis A in hepatitis B virus carrier

  Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin

  241-244

  05-04-2016

  https://doi.org/10.4081/itjm.2016.571

  1590

  PDF: 1040

  HTML: 686
• 

  Association of TNF-α, IFN-γ, IL-6, and IL-10 with different clinical manifestations of hepatitis B infection

  Mudathir Abdelshafea Abdelkareem Abakar, Ashwag Ali Hussein Ali, Eman Damra Ahmed Elhassan, Esra Ali Hamuda Altaher, Nosaiba Hussein Abdalbasit Musa, Shamsoun Khamis Kafi, Amira Eltom Fawzi Osman, Hisham Ali Waggiallah

  18-07-2023

  https://doi.org/10.4081/itjm.2023.1627

  1691

  PDF: 666

  HTML: 85
• 

  Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: results of a prospective multicentric study

  Antonio Ascione, Mario Masarone, Giovanni Tritto, Carmine Coppola, Cristina Mascolo, Marcello Persico, Giovanbattista Forte, Luca Fontanella, Massimo De Luca, Giovan Giuseppe Di Costanzo, the SCIROCCO Study Group

  176-181

  25-11-2013

  https://doi.org/10.4081/itjm.2013.409

  2096

  PDF: 1308

  HTML: 525
• 

  Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy

  Mario Masarone, Roberta Russo, Antonella Gambale, Concetta Langella, Ferdinando Carlo Sasso, Luca Fontanella, Marco Romano, Achille Iolascon, Marcello Persico

  61-70

  27-02-2014

  https://doi.org/10.4081/itjm.2014.443

  2119

  PDF: 1534

  HTML: 592

• Determinants of hepatitis B vaccination coverage in children aged 12-23 months: evidence from the Multiple Indicator Cluster Survey

  Husham O. Elzein, Elryah I. Ali, Mohammed Suleiman Zaroog, Eltigani O.M. Omer, Kamal Elbssir Mohammed Ali, Eltayeb I.O. Elmahi, Sara H.M. Hamad, Zakariya M.S. Mohammed

  09-09-2025

  https://doi.org/10.4081/itjm.2025.1976

  308

  PDF: 349

  HTML: 32
• 

  Pancreatic carcinoma development: new etiological and pathogenetic evidence

  Sirio Fiorino, Letizia Bacchi-Reggiani, Laura Pontoriero, Claudio Gallo, Elisabetta Chili, Michele Masetti, Nicola Zanini, Anna Grondona, Tania Silvestri, Gaia Deleonardi, Elisabetta Magrini, Roberto Motta, Adele Fornelli, Arrigo Bondi, Dario De Biase, Paola Baccarini, Giovanni Tallini, Antonio Tropeano, Andrea Cuppini, Gastone Castellani, Elio Jovine

  242-252

  17-12-2013

  https://doi.org/10.4081/itjm.2013.242

  2086

  PDF: 1183

  HTML: 222
• 

  Liver diseases and pregnancy

  Pietro Crispino, Luca Fontanella, Paola Gnerre

  278-287

  11-09-2017

  https://doi.org/10.4081/itjm.2017.817

  1732

  PDF: 919

  HTML: 324
• 

  Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2

  Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin

  82-88

  20-03-2015

  https://doi.org/10.4081/itjm.2015.471

  1352

  PDF: 892

  HTML: 283
• 

  Compliance with the clinical practice guidelines for the management of hepatitis B and C virus-related chronic liver disease: a survey based on hospitalized cirrhotic patients

  Emanuele La Spada, Giuseppe Augello, Giovanni Anastasi, Aldo Spadaro, Francesco Taormina, Felice Fiorello, Michele Stornello, Antonio Carroccio, Umberto Castiglione, Rocco Siciliano, Giuseppe Montalto, the Internal Medicine Collaborating Group

  107-112

  24-04-2013

  https://doi.org/10.4081/itjm.2013.107

  1452

  PDF: 869

  HTML: 329
• 

  Use of ursodeoxycholic acid in patients with hypertransaminasemia

  Claudio Puoti, Maria Giuseppa Elmo

  141-147

  18-09-2014

  https://doi.org/10.4081/itjm.2014.426

  1673

  PDF: 1146

  HTML: 1349
• 

  Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysis

  Wenze Wu, Fang Lin, Zifan Chen, Kejia Wu, Changhuan Ma, Jing Zhuang, Donglin Sun, Qiang Zhu, Longqing Shi

  06-09-2023

  https://doi.org/10.4081/itjm.2023.1626

  1216

  PDF: 541

  HTML: 76
• 

  HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

  Antonio Salvio, Maria Varriale, Tito d'Errico, Gennaro De Siena, Mario Visconti

  278-281

  02-01-2012

  https://doi.org/10.4081/itjm.2011.278

  1203

  PDF: 762
• 

  The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

  Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone

  82-89

  07-03-2013

  https://doi.org/10.4081/itjm.2011.82

  1263

  PDF: 1352
• 

  HIV, HCV and SARS-CoV-2: friends or foes? A case report

  Elena Garlatti Costa, Cesare Mazzaro, Alessandro Grembiale, Alessandro Berto, Rita De Rosa, Silvia Grazioli, Maurizio Tonizzo

  24-09-2021

  https://doi.org/10.4081/itjm.2021.1350

  1253

  PDF: 571

  HTML: 8

• P136 | Analysis of prevalence of hepatitis B and hepatitis C virus serum markers: a longitudinal study in a cohort of pregnant women from north-western Italy C. Smirne¹, M.G. Crobu², R. Rapetti¹, V. Remorgida³, M. Pirisi¹ | ¹Medicina Interna 1, AOU Maggiore della Carità, Novara, ²Laboratorio di Microbiologia e Virologia, AOU Maggiore della Carità, Novara, ³Ostetricia e Ginecologia, AOU Maggiore della Carità, Novara, Italy

  27-08-2025

  https://doi.org/10.4081/itjm.2025.2332

  130
• 

  Serum interleukin-6 is associated with hypocalcemia, hypoferritinemia and hyperkalemia in end-stage renal disease patients

  Ghassaq T. Alubaidi, Yasameen A. Humadi , Dalyia A. Hamoodi, Hasanain Tuama Mahdi , Bushra Auid Anid, Ilham Ahmed Jasim, Ibrahim Mohammed Abdalfatah

  30-12-2022

  https://doi.org/10.4081/itjm.2022.1550

  1633

  PDF: 528

  HTML: 70

• Expert consensus guideline on the diagnosis of type 1 Gaucher disease in adult patients

  Antonio De Vivo, Giovanni Marconi, Nicola Tumedei, Elisa Luicchini, Maria Chiara Finazzi, Ilaria Maria Burgo, Gian Luca Forni, Silvia Linari

  20-06-2024

  https://doi.org/10.4081/itjm.2024.1748

  1897

  PDF: 688

  SUPPLEMENTARY MATERIAL: 147

  HTML: 100

• P37 | Bulevirtide treatment for chronic HDV hepatitis: single-center experience N. Capoluongo¹, A. Izzi¹, L. Fontanella², G. D’Adamo³, A. Solano⁴, N. Cuomo⁵, A. Perrella¹ | ¹UOC of Emerging and Highly Contagious Infectious Diseases, Cotugno Hospital, Naples, ²Cardiovascular and Metabolic Internal Medicine, Monaldi Hospital, Naples, ³UOC Internal Medicine, Umberto I Hospital, Nocera Inferiore (SA), ⁴UOC Internal Medicine, Pellegrini Hospital, Naples, ⁵UOC Clinic Pathology, Cotugno Hospital, Naples, Italy

  26-08-2025

  https://doi.org/10.4081/itjm.2025.2229

  111